SEOUL (Reuters) – South Korea has secured 20,000 courses of an experimental antiviral pill developed by Merck & Co for
Continue reading »
mypharmacynews.com
Home ยป
SEOUL (Reuters) – South Korea has secured 20,000 courses of an experimental antiviral pill developed by Merck & Co for
Continue reading »FILE PHOTO: Women walk on an empty street amid tightened social distancing rules due to the coronavirus disease (COVID-19) pandemic
Continue reading »SEOUL (Reuters) – One dose of COVID-19 vaccines from AstraZeneca Plc and Pfizer was 86.6% effective in preventing infections among
Continue reading »